Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: Am J Hematol. 2023 Sep 9;98(12):1869–1876. doi: 10.1002/ajh.27084

Table 1.

Baseline characteristics of study participants

Characteristic Overall,
N = 3071
AML,
N = 2241
B-cell ALL,
N = 491
MPAL,
N = 151
T-cell ALL,
N = 181
Ambiguous lineage,
N = 11
Age 58 (46, 66) 60 (51, 67) 55 (40, 63) 55 (42, 63) 38 (30, 54) 27 (27, 27)
  Age ≥ 65 88 (29%) 77 (34%) 8 (16%) 2 (13%) 1 (5.6%) 0 (0%)
  Age ≥ 70 46 (15%) 44 (20%) 2 (4.1%) 0 (0%) 0 (0%) 0 (0%)
Sex
 Female 127 (41%) 102 (46%) 16 (33%) 5 (33%) 4 (22%) 0 (0%)
 Male 180 (59%) 122 (54%) 33 (67%) 10 (67%) 14 (78%) 1 (100%)
Broad Ancestry
 European 184 (60%) 133 (59%) 32 (65%) 9 (60%) 9 (50%) 1 (100%)
 Non-European 72 (23%) 52 (23%) 11 (22%) 4 (27%) 5 (28%) 0 (0%)
 Missing 51 (17%) 39 (17%) 6 (12%) 2 (13%) 4 (22%) 0 (0%)
Diagnosis type
 Newly diagnosed 251 (82%) 185 (83%) 36 (73%) 13 (87%) 16 (89%) 1 (100%)
 Refractory 19 (6.2%) 16 (7.1%) 3 (6.1%) 0 (0%) 0 (0%) 0 (0%)
 Relapsed 37 (12%) 23 (10%) 10 (20%) 2 (13%) 2 (11%) 0 (0%)
1

data summarized as median (IQR) and n (%); AML, acute myeloid leukemia; ALL, acute lymphoblastic leukemia; MPAL, mixed phenotypic acute leukemia; IQR, interquartile range.